Discontinued — last reported Q1 '20

Current Liabilities

Restructuring Reserve

Pfizer Restructuring Reserve decreased by 7.6% to $1.84B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 13.9%, from $2.13B to $1.84B. Over 4 years (FY 2020 to FY 2024), Restructuring Reserve shows an upward trend with a 27.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2020

How to read this metric

An increase suggests active cost-cutting or strategic realignment, which may lead to future margin expansion but indicates current operational friction.

Detailed definition

This liability captures the estimated costs associated with formal restructuring plans, such as severance packages, faci...

Peer comparison

Common in large financial institutions undergoing digital transformation or cost-rationalization programs.

Metric ID: restructuring_reserve

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$596.00M$1.14B$1.07B$952.00M$913.00M$867.00M$1.20B$750.00M$714.00M$585.00M$1.99B$1.64B$2.40B$2.13B$2.12B$2.40B$1.99B$1.84B
QoQ Change+90.4%-5.6%-11.1%-4.1%-5.0%+38.9%-37.7%-4.8%-18.1%+239.8%-17.6%+46.5%-11.1%-0.6%+13.2%-17.2%-7.6%
YoY Change+53.2%-23.6%+12.4%-21.2%-21.8%-32.5%+65.1%+118.4%+236.0%+264.4%+6.6%+46.5%-17.2%-13.9%
Range$585.00M$2.40B
CAGR+30.3%
Avg YoY Growth+48.0%
Median YoY Growth+9.5%
Current Streak2 quarters decline

Frequently Asked Questions

What is Pfizer's restructuring reserve?
Pfizer (PFE) reported restructuring reserve of $1.84B in Q3 2025.
How has Pfizer's restructuring reserve changed year-over-year?
Pfizer's restructuring reserve decreased by 13.9% year-over-year, from $2.13B to $1.84B.
What is the long-term trend for Pfizer's restructuring reserve?
Over 4 years (2020 to 2024), Pfizer's restructuring reserve has grown at a 27.7% compound annual growth rate (CAGR), from $798.00M to $2.12B.
What does restructuring reserve mean?
The estimated cost set aside for future business reorganization and downsizing activities.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.